4-((4-(4-(4-bromobenzyl)-1H-1,2,3-triazol-1-yl)piperidin-1-yl)methyl)aniline

ID: ALA4444356

Chembl Id: CHEMBL4444356

PubChem CID: 155517242

Max Phase: Preclinical

Molecular Formula: C21H24BrN5

Molecular Weight: 426.36

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1ccc(CN2CCC(n3cc(Cc4ccc(Br)cc4)nn3)CC2)cc1

Standard InChI:  InChI=1S/C21H24BrN5/c22-18-5-1-16(2-6-18)13-20-15-27(25-24-20)21-9-11-26(12-10-21)14-17-3-7-19(23)8-4-17/h1-8,15,21H,9-14,23H2

Standard InChI Key:  XFFULVCSYALHCN-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4444356

    ---

Associated Targets(Human)

BCL2L1 Tchem Bcl-xL/Bcl-2-binding component 3 (27 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD4 Tchem Dopamine D4 receptor (7907 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SIGMAR1 Tclin Sigma opioid receptor (6358 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 426.36Molecular Weight (Monoisotopic): 425.1215AlogP: 4.05#Rotatable Bonds: 5
Polar Surface Area: 59.97Molecular Species: BASEHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.70CX LogP: 3.68CX LogD: 2.36
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.63Np Likeness Score: -1.37

References

1. Ramana Murthy AV, Narendar V, Kumar NS, Aparna P, Durga Bhavani AK, Gautier F, Barillé-Nion S, Juin P, Mosset P, Grée R, Levoin N..  (2019)  Targeting PUMA/Bcl-xL interaction by new specific compounds to unleash apoptotic process in cancer cells.,  162  [PMID:30453244] [10.1016/j.ejmech.2018.10.069]
2. Levoin N, Murthy AVR, Narendar V, Kumar NS, Aparna P, Bhavani AKD, Reddy CR, Mosset P, Grée R..  (2022)  Discovery of potent dual ligands for dopamine D4 and σ1 receptors.,  69  [PMID:35753263] [10.1016/j.bmc.2022.116851]

Source